Market research
WHA.AU Wattle Health Australia Limited
AU AUD Consumer Defensive
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 109M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.65
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- ISIN
- AU0000162281
- Market cap
- 109M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.65
About
About Wattle Health Australia Limited
Wattle Health Australia Limited produces and sells organic nutritional milk products in Australia. The company offers a range of nutritional infant formula dairy products under the Uganic brand name. It also provides organic baby skincare products, aromatherapy essential oils, and cleaning and laundry products under the Little Innoscents brand name. The company also sells its dairy products through online. Wattle Health Australia Limited has a strategic partnership with Shepparton Partners Collective. The company was founded in 2011 and is headquartered in Abbotsford, Australia.
Research context
Wattle Health Australia Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the WHA.AU discussion.
5 years, 6 months ago
Wattle Health Australia Limited is currently in a long term downtrend where the price is trading 4.4% below its 200 day moving average.
From a valuation standpoint, the stock is 1810.0% more expensive than other stocks from the Consumer Defensive sector with a price to sales ratio of 129.7.
Wattle Health Australia Limited's total revenue rose by 38.1% to $714K since the same quarter in the previous year.
Its net income has dropped by 75.7% to $-17M since the same quarter in the previous year.
Finally, its free cash flow grew by 91.2% to $-2M since the same quarter in the previous year.
Based on the above factors, Wattle Health Australia Limited gets an overall score of 2/5.